Using a different experimental setting, a combination of anti-IFN-α and anti-IFN-β neutralizing antibodies was added at the beginning of ZIKV infection to block the effect of endogenous virus-induced IFN. This evidence concerns the gene IFNB1 and Zika virus infectious disease.